美国防务公司洛克希德马丁上涨至盘中最高点，涨幅达2.4%。乌克兰基辅星集团股价下跌3.5%，创下日内新低。

The FDA has approved Revolution Medicines' pancreatic cancer drug Daraxonrasib, which will be marketed as Rasonque. The drug is the first therapy targeting one of the disease's key molecular pathogenic mechanisms. A late-stage trial published in May showed Daraxonrasib nearly doubled typical survival in an aggressive form of pancreatic cancer to 13.2 months versus 6.7 months with chemotherapy, the current standard of care.

Kpler data show Iran holds more than 80 million barrels of oil outside the blockade zone, most already booked, which could provide Tehran with roughly 5–6 months of export revenue; after that, oil export income would disappear. The finding aligns with Central Bank Governor Abdolnaser Hemmati’s comment that oil exports have "almost stopped".